Prevent coadministration with sensitive CYP3A substrates. If coadministration unavoidable, monitor for adverse reactions and reduce CYP3A substrate dose in accordance with solution labeling.bosentan will lower the level or impact of triazolam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.It's essential to steadily le